申请人:Nakayama Kiyoshi
公开号:US20050009843A1
公开(公告)日:2005-01-13
A medicament for preventive and/or therapeutic treatment of a microbial infection which comprises as an active ingredient a compound represented by the following general formula (I):
wherein, R
1
and R
2
represent hydrogen atom, a halogen atom, hydroxyl group or the like, W
1
represents —CH═CH—, —CH
2
O—, —CH
2
CH
2
— or the like; R
3
represents hydrogen atom, a halogen atom, hydroxyl group or an amino group; R
4
represents hydrogen atom, a group of —OZ
0-4
R
5
(Z
0-4
represents an alkylene group, a fluorine-substituted alkylene group or a single bond, and R
5
represents a cyclic alkyl group, an aryl group or the like); W
2
represents a single bond or —C(R
8
)═C(R
9
)—(R
8
and R
9
represent hydrogen atom, a halogen atom, a lower alkyl group or the like, Q represents an acidic group, but W
2
and Q may together form vinylidenethiazolidinedione or an equivalent heterocyclic ring; m and n represent an integer of 0 to 2, and q represents an integer of 0 to 3.
预防和/或治疗微生物感染的药物,其活性成分为以下通用式(I)所表示的化合物:其中,R1和R2表示氢原子、卤原子、羟基或类似物,W1表示—CH═CH—、—CH2O—、—CH2CH2—或类似物;R3表示氢原子、卤原子、羟基或氨基;R4表示氢原子、—OZ0-4R5(Z0-4表示烷基、氟代烷基或单键,R5表示环烷基、芳基或类似物);W2表示单键或—C(R8)═C(R9)—(R8和R9表示氢原子、卤原子、低烷基或类似物,Q表示酸性基团,但W2和Q可以共同形成乙烯基噻唑烷二酮或等效的杂环环;m和n表示0至2的整数,q表示0至3的整数。